Arbutamine
- TRADE NAME: GenESA (Sicor)
- INDICATIONS: Diagnostic aid for coronary artery disease
- CLASS: Adrenergic beta-receptor agonist
- HALF-LIFE: 1.8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abacavir, Clidinium, Clomipramine, Desipramine, Dicyclomine, Digoxin, Doxepin, Flavoxate, Glycopyrrolate, Hyoscyamine, Imipramine, Mepenzolate, Methantheline, Nortriptyline, Oxybutynin, Procyclidine, Propantheline, Protriptyline, Scopolamine, Trihexyphenidyl, Trimipramine
Please login to see the rest of this drug profile
SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
RESPIRATORY
LOCAL
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric